Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-controlled Study Comparing Aflibercept Versus Placebo on the QTc Interval in Cancer Patients Treated With Docetaxel

NCT00876044 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00876044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00876044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-controlled Study Comparing Aflibercept Versus Placebo on the QTc Interval in Cancer Patients Treated With Docetaxel
Lead sponsor
Sanofi
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2009
Completion date
November 30, 2010
Enrollment
88 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cancer